| Bridging the gap: with a boost from the NRC, a small biotech company called PharmaGap limits the growth of cancer cells through gap junction modulation. ... An article from: Canadian Chemical News | Digitalby Jeff Pappone (Author)
| List Price: | $5.95 | | | Available: | Available for download now |
| | Binding: | Digital | | Publisher: | Chemical Institute of Canada | | Page Count: | 5 Pages | | Publication Date: | May 01, 2003 |
|
EDITORIAL REVIEWS |
Product Description
This digital document is an article from Canadian Chemical News, published by Chemical Institute of Canada on May 1, 2003. The length of the article is 1456 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle: Bridging the gap: with a boost from the NRC, a small biotech company called PharmaGap limits the growth of cancer cells through gap junction modulation. (Articles).Author: Jeff PapponePublication: Canadian Chemical News (Magazine/Journal)Date: May 1, 2003Publisher: Chemical Institute of CanadaVolume: 55 Issue: 5 Page: 22(2)Distributed by Thomson Gale |
|
